| NDC Code | 17772-133-30 |
|---|
| Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-30) |
|---|
| Product NDC | 17772-133 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Qelbree |
|---|
| Non-Proprietary Name | Viloxazine Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20210402 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA211964 |
|---|
| Manufacturer | Supernus Pharmaceuticals, Inc |
|---|
| Substance Name | VILOXAZINE HYDROCHLORIDE |
|---|
| Strength | 200 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA] |
|---|